1052117

Cadila Pharmaceuticals Limited — FEI 3007684569

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 3, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ahmedabad (India)

Citations

IDCFRDescription
188321 CFR 211.165(a)Testing and release for distribution